BRIP1 p.Arg798Ter
c.2392C>T · rs137852986 · VCV4738
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | nonsense (stop-gain) | predicted loss-of-function in a haploinsufficient gene (ClinGen) |
|---|---|---|
| NMD | predicted | premature termination codon in exon 17 of 20 |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 6.1 | GERP 1.5, phastCons 1 |
| Overall | ||
| CADD | 40.0 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0504% | 1,985 |
| European (non-Finnish)grpmax | 0.0348% | 2,875 |
| Admixed American | 0.0135% | 7,434 |
| African / African-American | 0.0107% | 9,327 |
| South Asian | 0.00348% | 28,713 |
| East Asian | 0.00226% | 44,290 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- BRIP1
- Protein
- p.Arg798Ter
- Coding
- c.2392C>T
- MANE Select
- NM_032043
- dbSNP
- rs137852986
- Type
- single nucleotide variant
- Location
- chr17:61716051 (GRCh38)
- Gene constraint
- LOEUF 0.848 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 64.19 · 6 PDB
Disease context
Also linked: gastric cancerbreast cancerovarian canceresophageal atresia/tracheoesophageal fistulabreast-ovarian cancer, familial, susceptibility to, 1Fanconi anemia complementation group Jhereditary neoplastic syndromefamilial ovarian cancerhereditary breast carcinomaFanconi anemia
Similar variants
- BRIP1 p.Arg798Gln Uncertain significance ★★ ⚠ same residue
- BRIP1 p.Arg798Pro Uncertain significance ★ ⚠ same residue
- BRIP1 p.Arg798= Likely benign ★ same residue
- BRIP1 p.Arg798fs Pathogenic ★★ same residue
- BRIP1 c.1140+1G>A Likely pathogenic ★★ same condition
- BRIP1 c.1141-2A>C Likely pathogenic ★★ same condition
- BRIP1 c.1141-2A>G Likely pathogenic ★★ same condition
- BRIP1 c.1141-2A>T Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/brip1-p-arg798ter (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown